Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
JP Stock MarketDetailed Quotes
4572 Carna Biosciences
- 300
- +5+1.69%
20min DelayMarket Closed Dec 30 15:30 JST
5.73BMarket Cap-4.37P/E (Static)
307High293Low168.70KVolume295Open295Pre Close51.01MTurnover53852wk High1.11%Turnover Ratio19.11MShares26352wk Low-78.06EPS TTM4.57BFloat Cap6030Historical HighLossP/E (Static)15.23MShs Float195Historical Low-68.62EPS LYR4.75%Amplitude--Dividend TTM1.78P/B100Lot Size--Div YieldTTM
About Carna Biosciences Company
Carna Biosciences Inc is a Japanese company engaged in drug discovery support business and drug discovery and development business. The company identifies and develops medicines for the treatment of cancer and inflammatory diseases using own kinase drug discovery platform, QuickScout.
Company Profile
Symbol4572
Company NameCarna Biosciences
Founded2003-04-10
MarketTSE Growth
Employees64
Fiscal Year Ends12-31
AddressBMA 3F 1-5-5 Minatojima-Minamimachi
Zip Code650-0047
Phone078-302-7039
Websitewww.carnabio.com
Company Executives
- Name
- Position
- Salary
- Koichiro Yoshino
- President and Chief Executive Officer
- --
- Masaaki Sawa
- Chief Scientific Officer
- --
- Teruo Takayanagi
- Director and Chief Development Officer, CarnaBioUSA
- --
- Norio Aikawa
- Director of Business Management, Accounting, Human Resources and General Affairs, CarnaBioUSA
- --
- Kaori Suzuki
- Independent Director
- --
- Tsuguo Ogasawara
- Independent Director
- --
- Tokuo Arita
- Independent Director
- --
- Takao Matsui
- Independent Director
- --